| Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria C Duvoux, F Roudot–Thoraval, T Decaens, F Pessione, H Badran, ... Gastroenterology 143 (4), 986-994. e3, 2012 | 907 | 2012 |
| Immunological disorders in C virus chronic active hepatitis: a prospective case‐control study JM Pawlotsky, MB Yahia, C Andre, MC Voisin, L Intrator, ... Hepatology 19 (4), 841-848, 1994 | 690 | 1994 |
| Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study C Duvoux, D Zanditenas, C Hézode, A Chauvat, JL Monin, ... Hepatology 36 (2), 374-380, 2002 | 517 | 2002 |
| Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial EK Geissler, AA Schnitzbauer, C Zülke, PE Lamby, A Proneth, C Duvoux, ... Transplantation 100 (1), 116-125, 2016 | 446 | 2016 |
| Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives D Cherqui, A Laurent, C Tayar, S Chang, JT Van Nhieu, J Loriau, ... Annals of surgery 243 (4), 499-506, 2006 | 369 | 2006 |
| Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial P De Simone, F Nevens, L De Carlis, HJ Metselaar, S Beckebaum, ... American Journal of Transplantation 12 (11), 3008-3020, 2012 | 348 | 2012 |
| Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study LS Belli, M Berenguer, PA Cortesi, M Strazzabosco, SR Rockenschaub, ... Journal of hepatology 65 (3), 524-531, 2016 | 330 | 2016 |
| Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the consensus on … JM Neuberger, WO Bechstein, DRJ Kuypers, P Burra, F Citterio, ... Transplantation 101 (4S), S1-S56, 2017 | 299 | 2017 |
| Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation D Cherqui, A Laurent, N Mocellin, C Tayar, A Luciani, JT Van Nhieu, ... Annals of Surgery 250 (5), 738-746, 2009 | 297 | 2009 |
| Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study D Haldar, B Kern, J Hodson, MJ Armstrong, R Adam, G Berlakovich, ... Journal of hepatology 71 (2), 313-322, 2019 | 273 | 2019 |
| 2018 annual report of the European Liver Transplant Registry (ELTR)–50‐year evolution of liver transplantation R Adam, V Karam, V Cailliez, JG O Grady, D Mirza, D Cherqui, ... Transplant International 31 (12), 1293-1317, 2018 | 271 | 2018 |
| Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma T Decaens, F Roudot‐Thoraval, S Bresson‐Hadni, C Meyer, ... Liver Transplantation 11 (7), 767-775, 2005 | 268 | 2005 |
| Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease. M Michel, C Duvoux, C Hezode, D Cherqui The Journal of rheumatology 30 (7), 1624-1625, 2003 | 262 | 2003 |
| Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) 1 G Levy, P Burra, A Cavallari, C Duvoux, J Lake, AD Mayer, S Mies, ... Transplantation 73 (6), 953-959, 2002 | 231 | 2002 |
| Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry LS Belli, G Perricone, R Adam, PA Cortesi, M Strazzabosco, R Facchetti, ... Journal of hepatology 69 (4), 810-817, 2018 | 217 | 2018 |
| Impact of UCSF criteria according to pre‐and post‐OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time T Decaens, F Roudot‐Thoraval, S Hadni‐Bresson, C Meyer, ... Liver Transplantation 12 (12), 1761-1769, 2006 | 215 | 2006 |
| Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France C Taille, J Cadranel, A Bellocq, G Thabut, O Soubrane, F Durand, P Ichaï, ... Transplantation 75 (9), 1482-1489, 2003 | 211 | 2003 |
| Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC A Notarpaolo, R Layese, P Magistri, M Gambato, M Colledan, G Magini, ... Journal of hepatology 66 (3), 552-559, 2017 | 209 | 2017 |
| Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study F Saliba, P De Simone, F Nevens, L De Carlis, HJ Metselaar, ... American journal of transplantation 13 (7), 1734-1745, 2013 | 197 | 2013 |
| A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for … AA Schnitzbauer, C Zuelke, C Graeb, J Rochon, I Bilbao, P Burra, ... BMC cancer 10, 1-8, 2010 | 186 | 2010 |
